Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Airsculpt Technologies Inc (AIRS)

Healthcare Medical Care Facilities
4.80 $
-0.8% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Airsculpt Technologies Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 5 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
4.90$
Open
4.90$
Day High
4.90$
Day Low
4.60$
Volume
353,652shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
1.60 $ 11.70 $
02/27/2026 10/27/2025

Current price 4.80 $ — 32% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.3$B
Shares Outstanding
71Mio.
Float
21.2%
Beta
2.4

Performance

Perf. 1M
-18.40%
Perf. 3M
57.50%
Perf. 6M
108.30%
YTD Performance (%)
132.30%
52-Week-High Distance
-63.2%
Perf. 1Y
-27.23%
Perf. 3Y
-46.97%
Perf. 5Y
-70.16%
Perf. Since Inception
-68.42%

Technical Indicators

MA 38 Days
4.60$
MA 50 Days
4.80$
MA 200 Days
4.00$
RSI (14)
55.8
Volatility 30 Days
59.2%
Volatility 250 Days
120.1%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
0.0
PEG
P/B
P/S
2.3
EV/EBITDA
403.5
Price/FCF
50.0

Profitability

Gross Margin
66.1%
EBIT Margin
Net Margin
-7.4%
Return on Equity
-12.6%
Return on Assets
-1.6%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
Altman Z″
3.10
Piotroski
7 out of 9

Growth

Sales Growth Last Quarter
0.00%
EPS Growth Last Quarter
200.00%
Sales Growth (Year)
-15.82%
Forward Sales Growth
2.51%
Forward EPS Growth
33.30%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
3
RS Rating
81
Top 10%
EPS Rating
90
Piotroski
7 out of 9
Fundamental Rating
D (35 out of 100)
Altman Z″
3.10

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 4.80 $
Price Target (average) 4.50 $

The price target sits 6.2% below the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

7. Aug 2026 · before the open · Q2 2026
Expected Earnings per Share
0.02 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 39.2 $M Q4 2025: Q1 · 39.4 $M Q1 2025: Q2 · 44.0 $M Q2 2025: Q3 · 35.0 $M Q3 2025: Q4 · 33.4 $M Q4 2026: Q1 · 39.4 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.07 39 -17.70 -12.80 3 -1
2025: Q1 -0.04 -147.20 39 -17.30 -7.20 1 -1
2025: Q2 -0.01 44 -13.70 -1.30 5 5
2025: Q3 -0.13 35 -17.80 -27.20 0 0
2025: Q4 0.02 33 -14.60 3.80 -3 -3
2026: Q1 -0.03 39 0.00 -6.10 5 5
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

AirSculpt Technologies, Inc. fungiert zusammen mit seinen Tochtergesellschaften als Holdinggesellschaft für EBS Intermediate Parent LLC, die Body-Contouring-Verfahren in den USA und Kanada anbietet.

Employees330
HeadquartersMiami Beach, FL
Websiteairsculpt.com
IPO Date29. Oct 2021

Management

Management
Name Title Birth Year
Yogesh Jashnani CEO & Director 1982
Michael J. Arthur Chief Financial Officer 1988
Brent R. Wadman J.D. General Counsel 1972
Stephanie Evans Greene Chief Marketing Officer

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
17. Apr 2026 Jorey Chernett Major Shareholder Buy 40,000 2.54 101,600

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?